← FDA DRUG APPROVALS

FDA ANDA · ANDA077317

ISRADIPINE

Sponsor: WATSON LABS TEVA

APPLICATION
ANDA077317
TYPE
ANDA
ORIGINAL APPROVAL
2006-01-05
LATEST ACTION
2006-01-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ISRADIPINEPrescription
ISRADIPINE 2.5MG · CAPSULE · ORAL
ISRADIPINEPrescription
ISRADIPINE 5MG · CAPSULE · ORAL

Approval history

2006-01-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →